Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: Potential complication and long-term assessment of ablation adequacy

D. Brooke Johnson, M. Hossein Saboorian, David A. Duchene, Kenneth Ogan, Jeffrey A Cadeddu

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Little information is available concerning the morbidity of radiofrequency ablation (RFA) or the evolution of an RFA lesion over time. We report our findings in a kidney removed 1 year after RFA of a 2.3-cm renal tumor. After RFA, the patient experienced flank pain, followed by hydronephrosis, ureteropelvic junction obstruction, and eventual loss of function in the treated kidney. Nephrectomy revealed no residual renal cell carcinoma. RFA can completely destroy renal cell carcinoma in situ without histologic evidence of persistence or recurrence for up to 1 year after treatment. Care must be taken to avoid concurrent damage to the collecting system.

Original languageEnglish (US)
JournalUrology
Volume62
Issue number2
DOIs
StatePublished - Aug 1 2003

Fingerprint

Nephrectomy
Kidney
Renal Cell Carcinoma
Flank Pain
Hydronephrosis
Carcinoma in Situ
Morbidity
Recurrence
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction : Potential complication and long-term assessment of ablation adequacy. / Johnson, D. Brooke; Saboorian, M. Hossein; Duchene, David A.; Ogan, Kenneth; Cadeddu, Jeffrey A.

In: Urology, Vol. 62, No. 2, 01.08.2003.

Research output: Contribution to journalArticle

@article{3a966d4a06304bbe9d7c0e7278e3bd77,
title = "Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: Potential complication and long-term assessment of ablation adequacy",
abstract = "Little information is available concerning the morbidity of radiofrequency ablation (RFA) or the evolution of an RFA lesion over time. We report our findings in a kidney removed 1 year after RFA of a 2.3-cm renal tumor. After RFA, the patient experienced flank pain, followed by hydronephrosis, ureteropelvic junction obstruction, and eventual loss of function in the treated kidney. Nephrectomy revealed no residual renal cell carcinoma. RFA can completely destroy renal cell carcinoma in situ without histologic evidence of persistence or recurrence for up to 1 year after treatment. Care must be taken to avoid concurrent damage to the collecting system.",
author = "Johnson, {D. Brooke} and Saboorian, {M. Hossein} and Duchene, {David A.} and Kenneth Ogan and Cadeddu, {Jeffrey A}",
year = "2003",
month = "8",
day = "1",
doi = "10.1016/S0090-4295(03)00361-3",
language = "English (US)",
volume = "62",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction

T2 - Potential complication and long-term assessment of ablation adequacy

AU - Johnson, D. Brooke

AU - Saboorian, M. Hossein

AU - Duchene, David A.

AU - Ogan, Kenneth

AU - Cadeddu, Jeffrey A

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Little information is available concerning the morbidity of radiofrequency ablation (RFA) or the evolution of an RFA lesion over time. We report our findings in a kidney removed 1 year after RFA of a 2.3-cm renal tumor. After RFA, the patient experienced flank pain, followed by hydronephrosis, ureteropelvic junction obstruction, and eventual loss of function in the treated kidney. Nephrectomy revealed no residual renal cell carcinoma. RFA can completely destroy renal cell carcinoma in situ without histologic evidence of persistence or recurrence for up to 1 year after treatment. Care must be taken to avoid concurrent damage to the collecting system.

AB - Little information is available concerning the morbidity of radiofrequency ablation (RFA) or the evolution of an RFA lesion over time. We report our findings in a kidney removed 1 year after RFA of a 2.3-cm renal tumor. After RFA, the patient experienced flank pain, followed by hydronephrosis, ureteropelvic junction obstruction, and eventual loss of function in the treated kidney. Nephrectomy revealed no residual renal cell carcinoma. RFA can completely destroy renal cell carcinoma in situ without histologic evidence of persistence or recurrence for up to 1 year after treatment. Care must be taken to avoid concurrent damage to the collecting system.

UR - http://www.scopus.com/inward/record.url?scp=0041622650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041622650&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(03)00361-3

DO - 10.1016/S0090-4295(03)00361-3

M3 - Article

C2 - 12893355

AN - SCOPUS:0041622650

VL - 62

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -